Show simple item record

dc.creatorShamasunder, Bhavnaen
dc.creatorBero, Lisaen
dc.date.accessioned2016-01-09T00:17:58Zen
dc.date.available2016-01-09T00:17:58Zen
dc.date.created2002-08-14en
dc.date.issued2002-08-14en
dc.identifierdoi:10.1001/jama.288.6.738en
dc.identifier.bibliographicCitationJAMA: The Journal of the American Medical Association 2002 August 14; 288(6): 738-744en
dc.identifier.urihttp://worldcatlibraries.org/registry/gateway?version=1.0&url_ver=Z39.88-2004&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&atitle=Financial+ties+and+conflicts+of+interest+between+pharmaceutical+and+tobacco+companies&title=JAMA:+The+Journal+of+the+American+Medical+Association+&volume=288&issue=6&spage=738-744&date=2002-08&au=Shamasunder,+Bhavna;+Bero,+Lisaen
dc.identifier.urihttp://dx.doi.org/10.1001/jama.288.6.738en
dc.identifier.urihttp://hdl.handle.net/10822/1008499en
dc.description.abstractCorporate diversification allows for well-hidden financial ties between pharmaceutical and tobacco companies, which can cause a conflict of interest in the development and marketing of pharmaceutical products. In our investigation of tobacco company documents released and posted on the Internet as a result of the Master Settlement Agreement, we have found that these financial ties have fostered both competition and collaboration between the tobacco and pharmaceutical industries. We present 3 case studies. One shows how tobacco companies pressured pharmaceutical companies to scale back their smoking cessation educational materials that accompanied Nicorette. The second shows how they restricted to whom the pharmaceutical company could market its transdermal nicotine patch. In the third case, we show how subsidiary tobacco and pharmaceutical companies of a parent company collaborated in the production of a nicotine-release gum. Thus, because tobacco cessation product marketing has been altered as a result of these financial conflicts, disclosure would serve the interest of public health.en
dc.formatArticleen
dc.languageenen
dc.sourceeweb:249009en
dc.subjectCase Studiesen
dc.subjectConflict of Interesten
dc.subjectDisclosureen
dc.subjectHealthen
dc.subjectInterneten
dc.subjectMarketingen
dc.subjectPublic Healthen
dc.subjectSmokingen
dc.subject.classificationDrugs and Drug Industryen
dc.subject.classificationBusiness Ethicsen
dc.subject.classificationHealth Care for Substance Abusers / Users of Controlled Substancesen
dc.titleFinancial Ties and Conflicts of Interest Between Pharmaceutical and Tobacco Companiesen
dc.provenanceCitation prepared by the Library and Information Services group of the Kennedy Institute of Ethics, Georgetown University for the ETHXWeb database.en
dc.provenanceCitation migrated from OpenText LiveLink Discovery Server database named EWEB hosted by the Bioethics Research Library to the DSpace collection EthxWeb hosted by DigitalGeorgetown.en


This item appears in the following Collection(s)

Show simple item record


Georgetown University Seal
©2009—2019 Bioethics Research Library
Box 571212 Washington DC 20057-1212
202.687.3885